Comprehensive Psychiatry
Volume 46, Issue 1 , Pages 14-19 , January 2005

Cluster analysis of obsessive-compulsive spectrum disorders in patients with obsessive-compulsive disorder: clinical and genetic correlates

  • Christine Lochner

      Affiliations

    • MRC Unit on Anxiety and Stress Disorders, Department of Psychiatry, University of Stellenbosch, PO Box 19063, Tygerberg, 7505, Cape Town, South Africa
    • Corresponding Author InformationCorresponding author. PO Box 19063, Tygerberg 7505, South Africa. Tel.: +27 21 938 9179; fax: +27 21 933 5790.
    • ,
  • Sian M.J. Hemmings

      Affiliations

    • MRC/US Center for Molecular and Cellular Biology, University of Stellenbosch, Tygerberg, 7505, Cape Town, South Africa
    • ,
  • Craig J. Kinnear

      Affiliations

    • MRC/US Center for Molecular and Cellular Biology, University of Stellenbosch, Tygerberg, 7505, Cape Town, South Africa
    • ,
  • Dana J.H. Niehaus

      Affiliations

    • MRC Unit on Anxiety and Stress Disorders, Department of Psychiatry, University of Stellenbosch, PO Box 19063, Tygerberg, 7505, Cape Town, South Africa
    • ,
  • Daniel G. Nel

      Affiliations

    • Center for Statistical Consultation, Department of Statistics & Actuarial Science, University of Stellenbosch, Stellenbosch, Matieland, 7602, South Africa
    • ,
  • Valerie A. Corfield

      Affiliations

    • MRC/US Center for Molecular and Cellular Biology, University of Stellenbosch, Tygerberg, 7505, Cape Town, South Africa
    • ,
  • Johanna C. Moolman-Smook

      Affiliations

    • MRC/US Center for Molecular and Cellular Biology, University of Stellenbosch, Tygerberg, 7505, Cape Town, South Africa
    • ,
  • Soraya Seedat

      Affiliations

    • MRC Unit on Anxiety and Stress Disorders, Department of Psychiatry, University of Stellenbosch, PO Box 19063, Tygerberg, 7505, Cape Town, South Africa
    • ,
  • Dan J. Stein

      Affiliations

    • MRC Unit on Anxiety and Stress Disorders, Department of Psychiatry, University of Stellenbosch, PO Box 19063, Tygerberg, 7505, Cape Town, South Africa

References 

  1. Feinstein SB, Fallon BA, Petkova E, Liebowitz MR. Item-by-item factor analysis of the Yale-Brown Obsessive-Compulsive Scale symptom checklist. J. Neuropsychiatry Clin. Neurosci. 2003;15:187–193
  2. Lochner C, Stein DJ. Heterogeneity of obsessive-compulsive disorder: a literature review. Harv. Rev. Psychiatry. 2003;11:113–132
  3. Jenike MA. Pharmacologic treatment of obsessive compulsive disorders. Psychiatr. Clin. North Am. 1992;15:895–919
  4. Goodman WK, McDougle CJ, Price LH, Riddle MA, Pauls DL, Leckman JF. Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder?. J. Clin. Psychiatry. 1990;51(Suppl.):36–43
  5. McDougle CJ, Goodman WK, Price LH. Dopamine antagonists in tic-related and psychotic spectrum obsessive compulsive disorder. J. Clin. Psychiatry. 1994;55(Suppl.):24–31
  6. Cabib S, Puglisi-Allegra S. Different effects of repeated stressful experiences on mesocortical and mesolimbic dopamine metabolism. Neuroscience. 1996;73:375–380
  7. Thierry AM, Tassin JP, Blanc G, Glowinski J. Selective activation of mesocortical DA system by stress. Nature. 1976;263:242–244
  8. McDougle CJ, Goodman WK, Leckman JF, Lee NC, Heninger GR, Price LH. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics. Arch. Gen. Psychiatry. 1994;51:302–308
  9. McDougle CJ, Goodman WK, Leckman JF, Barr LC, Heninger GR, Price LH. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder. J. Clin. Psychopharmacol. 1993;13:354–358
  10. Nestadt G, Addington A, Samuels J, et al. The identification of OCD-related subgroups based on comorbidity. Biol. Psychiatry. 2003;53:914–920
  11. du Toit PL, van Kradenburg J, Niehaus D, Stein DJ. Comparison of obsessive-compulsive disorder patients with and without comorbid putative obsessive-compulsive spectrum disorders using a structured clinical interview. Compr. Psychiatry. 2001;42:291–300
  12. McElroy SL, Phillips KA, Keck PE. Obsessive compulsive spectrum disorder. J. Clin. Psychiatry. 1994;55(Suppl.):33–51
  13. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington (DC): American Psychiatric Association; 1994;
  14. First MB, Spitzer RL, Gobbon M, Williams JBW. Structured clinical interview for DSM-IV Axis I disorders-Patient edition (SCID-I/P, Version 2.0, 8/98 revision). New York: New York State Psychiatric Institute, Biometrics Research Department; 1998;
  15. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown obsessive compulsive scale: I. Development, use, and reliability. Arch. Gen. Psychiatry. 1989;46:1006–1011
  16. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown obsessive compulsive scale: II. Validity. Arch. Gen. Psychiatry. 1989;46:1012–1016
  17. Leckman JF, Riddle MA, Hardin MT, et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J. Am. Acad. Child Adolesc. Psychiatry. 1989;28:566–573
  18. Guy, W. ECDEU assessment manual for psychopharmacology. Washington (DC): Superintendent of Documents, U.S. Government Printing Office, U.S. Department of Health, Education, and Welfare; 1976 [Publication No. 76-338].
  19. Bernstein DP, Fink L, Handelsman L, et al. Initial reliability and validity of a new retrospective measure of child abuse and neglect. Am. J. Psychiatry. 1994;151:1132–1136
  20. Cloninger CR, Przybeck TR, Svrakic DM, Wetzel RD. The temperament and character inventory: a guide to its development and use. Washington University (St. Louis, Missouri): Center for Psychobiology of Personality; 1994;
  21. Hemmings SMJ, Kinnear CJ, Niehaus DJH, et al. Investigating the role of dopaminergic and serotonergic candidate genes in obsessive-compulsive disorder. Eur. Neuropsychopharmacol. 2003;13:93–98
  22. Lichter JB, Barr CL, Kennedy JL, Van Tol HH, Kidd KK, Livak KJ. A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. Hum. Mol. Genet. 1993;2:767–773
  23. Vandenbergh DJ, Persico AM, Hawkins AL, et al. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics. 1992;14:1104–1106
  24. Heils A, Teufel A, Petri S, et al. Allelic variation of human serotonin transporter gene expression. J. Neurochem. 1996;66:2621–2624
  25. Sidenberg DG, Bassett AS, Demchyshyn L, et al. New polymorphism for the human serotonin 1D receptor variant (5-HT1D beta) not linked to schizophrenia in five Canadian pedigrees. Hum. Hered. 1993;43:315–318
  26. Warren JT, Peacock ML, Rodriguez LC, Fink JK. An MspI polymorphism in the human serotonin receptor gene (HTR2): detection by DGGE and RFLP analysis. Hum. Mol. Genet. 1993;2:338
  27. Ishiguro H, Arinami T, Saito T, et al. Systematic search for variations in the tyrosine hydroxylase gene and their associations with schizophrenia, affective disorders, and alcoholism. Am. J. Med. Genet. 1998;81:388–396
  28. Karayiorgou M, Altemus M, Galke BL, et al. Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proc. Natl. Acad. Sci. U. S. A. 1997;94:4572–4575
  29. Hotamisligil GS, Breakefield XO. Human monoamine oxidase A gene determines levels of enzyme activity. Am. J. Hum. Genet. 1991;49:383–392
  30. Ward JH. Hierarchical grouping to optimize an objective function. J. Am. Stat. Assoc. 1963;58:236–244
  31. Efron B, Tibshirani R. An introduction to the bootstrap. London: Chapman and Hall; 1993;
  32. Bergh C, Eklund T, Sodersten P, Nordin C. Altered dopamine function in pathological gambling. Psychol. Med. 1997;27:473–475
  33. Hollander E, Buchalter AJ, DeCaria CM. Pathological gambling. Psychiatr. Clin. North Am. 2000;23:629–642
  34. Seedat S, Kesler S, Niehaus DJ, Stein DJ. Pathological gambling behaviour: emergence secondary to treatment of Parkinson's disease with dopaminergic agents. Depress. Anxiety. 2000;11:185–186
  35. Singer HS, Hahn IH, Moran TH. Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette's syndrome. Ann. Neurol. 1991;30:558–562
  36. Stein DJ, Hollander E. Low-dose pimozide augmentation of serotonin reuptake blockers in the treatment of trichotillomania. J. Clin. Psychiatry. 1992;53:123–126
  37. Blum K, Braverman ER, Holder JM, et al. Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. J. Psychoactive Drugs. 2000;32(Suppl.):i–112
  38. do Rosario-Campos MC, Leckman JF, Mercadante MT, et al. Adults with early-onset obsessive-compulsive disorder. Am. J. Psychiatry. 2001;158:1899–1903
  39. Eichstedt JA, Arnold SL. Childhood-onset obsessive-compulsive disorder: a tic-related subtype of OCD?. Clin. Psychol. Rev. 2001;21:137–157
  40. Geller D, Biederman J, Jones J, et al. Is juvenile obsessive-compulsive disorder a developmental subtype of the disorder? A review of the pediatric literature. J. Am. Acad. Child Adolesc. Psychiatry. 1998;37:420–427
  41. George MS, Trimble MR, Ring HA, Sallee FR, Robertson MM. Obsessions in obsessive-compulsive disorder with and without Gilles de la Tourette's syndrome. Am. J. Psychiatry. 1993;150:93–97
  42. Hollander E, Greenwald S, Neville D, Johnson J, Hornig CD, Weissman MM. Uncomplicated and comorbid obsessive-compulsive disorder in an epidemiologic sample. Depress. Anxiety. 1996;4:111–119
  43. Hollander E, Rosen J. Impulsivity. J. Psychopharmacol. 2000;14:S39–S44
  44. Manchanda R, Sethi BB, Gupta SC. Hostility and guilt in obsessive-compulsive neurosis. Br. J. Psychiatry. 1979;135:52–54
  45. Millar DG. Hostile emotion and obsessional neurosis. Psychol. Med. 1983;13:813–819
  46. Stein DJ, Hollander E. The spectrum of obsessive-compulsive related disorders. In:  Hollander E editors. Obsessive-compulsive related disorders. Washington (DC): American Psychiatric Press; 1993;
  47. Stein DJ, Hollander E. Impulsive aggression and obsessive-compulsive disorder. Psychiatr. Ann. 1993;23:389–395
  48. Stein DJ, Hollander E, Simeon D, Cohen L. Impulsivity scores in patients with obsessive-compulsive disorder. J. Nerv. Ment. Dis. 1994;182:240–241
  49. Thornton C, Russell J. Obsessive compulsive comorbidity in the dieting disorders. Int. J. Eat. Disord. 1997;21:83–87
  50. Winchel RM, Stanley M. Self-injurious behavior: a review of the behavior and biology of self-mutilation. Am. J. Psychiatry. 1991;148:306–317
  51. Bogetto F, Venturello S, Albert U, Maina G, Ravizza L. Gender-related clinical differences in obsessive-compulsive disorder. Eur. Psychiatry. 1999;14:434–441
  52. de Silva P, Marks M. The role of traumatic experiences in the genesis of obsessive-compulsive disorder. Behav. Res. Ther. 1999;37:941–951
  53. Fallon BA, Qureshi AI, Laje G, Klein B. Hypochondriasis and its relationship to obsessive-compulsive disorder. Psychiatr. Clin. North Am. 2000;23:605–616
  54. Paul T, Schroeter K, Dahme B, Nutzinger DO. Self-injurious behavior in women with eating disorders. Am. J. Psychiatry. 2002;159:408–411
  55. Yates TM. The developmental psychopathology of self-injurious behavior: compensatory regulation in posttraumatic adaptation. Clin. Psychol. Rev. 2004;24:35–74
  56. Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character. Arch. Gen. Psychiatry. 1993;50:975–990
  57. Kavoussi RJ, Coccaro EF. Biology and pharmacological treatment of impulse-control disorders. In:  Oldham JM,  Hollander E,  Skodol AE editor. Impulsivity and compulsivity. Washington (DC): APA Inc.; 1996;p. 119–142
  58. Altamura C, Paluello MM, Mundo E, Medda S, Mannu P. Clinical and subclinical body dysmorphic disorder. Eur. Arch. Psychiatry Clin. Neurosci. 2001;251:105–108
  59. Phillips KA, Gunderson CG, Mallya G, McElroy SL, Carter W. A comparison study of body dysmorphic disorder and obsessive-compulsive disorder. J. Clin. Psychiatry. 1998;59:568–575
  60. Stein DJ, Fineberg N, Harvey B. Unusual symptoms of OCD. In:  Fineberg N,  Marazziti D,  Stein DJ editor. Obsessive-compulsive disorder: a practical guide. London: Martin Dunitz Ltd.; 2001;p. 37–50
  61. Simeon D, Hollander E, Stein DJ, Cohen L, Aronowitz B. Body dysmorphic disorder in the DSM-IV field trial for obsessive-compulsive disorder. Am. J. Psychiatry. 1995;152:1207–1209

PII: S0010-440X(04)00108-7

doi: 10.1016/j.comppsych.2004.07.020

Comprehensive Psychiatry
Volume 46, Issue 1 , Pages 14-19 , January 2005

Article Tools

* Image Usage & Resolution